Pri-Med South

Fort Lauderdale, FL | February 6-9, 2020

Greater Ft. Lauderdale Broward County Convention Center

Primary Care Updates from the American Diabetes Association

Description

This talk will cover recent clinical trials presented at the ADA in 2019 that have an impact on the management of diabetes, such as cardiovascular outcomes trials and the first oral GLP-1 RA phase 3 data. The faculty will take you through the latest guidelines from the ADA regarding the management of type 2 diabetes and describe how recent clinical trial data has been integrated in to these guidelines. After this meeting review, you will be equipped to manage type 2 diabetes based on these guidelines.

Learning Objectives

Recognize how recent clinical trial data impacts the management of type 2 diabetes

Recognize how the new guidelines impact the medical management of type 2 diabetes

Integrate new knowledge to manage type 2 diabetes optimally


Speakers

Martin J. Abrahamson, MD, FACP

Martin J. Abrahamson, MD, is associate professor of medicine at Harvard Medical School, director of the Division of Continuing Medical Education in the Department of Medicine, and an active faculty member of the Endocrine Division, Department of Medi...

View Full Bio